March 2012
Volume 53, Issue 14
Free
ARVO Annual Meeting Abstract  |   March 2012
Iron Chelation Protects Against Murine Retinal Degeneration Induced Through Diverse Mechanisms
Author Affiliations & Notes
  • Joshua L. Dunaief
    FM Kirby Ctr/Ophthalmology,
    University of Pennsylvania, Philadelphia, Pennsylvania
  • Majda Hadziahmetovic
    FM Kirby Ctr, Scheie Eye Institute Univ of Penn, Philadelphia, Pennsylvania
  • Delu Song
    Dept of Ophthalmology, Peking Union Med College Hosp, Beijing, China
  • Ying Song
    Dept of Ophthalmology,
    University of Pennsylvania, Philadelphia, Pennsylvania
  • Yafeng Li
    Dept of Ophthalmology,
    University of Pennsylvania, Philadelphia, Pennsylvania
  • Steve Grieco
    FM Kirby Ctr/Ophthalmology,
    University of Pennsylvania, Philadelphia, Pennsylvania
  • Sally Chu
    FM Kirby Ctr/Ophthalmology,
    University of Pennsylvania, Philadelphia, Pennsylvania
  • John Connelly
    ApoPharma, Inc., Toronto, Ontario, Canada
  • Michael Spino
    ApoPharma, Inc., Toronto, Ontario, Canada
  • Footnotes
    Commercial Relationships  Joshua L. Dunaief, Deferiprone for retinal disease (P), Research funding from ApoPharma, Inc (F); Majda Hadziahmetovic, None; Delu Song, None; Ying Song, None; Yafeng Li, None; Steve Grieco, None; Sally Chu, None; John Connelly, employer manufactures Deferiprone (E); Michael Spino, Deferiprone for retinal disease (P), employer manufactures deferiprone (E)
  • Footnotes
    Support  Research to Prevent Blindness, ApoPharma, Inc., F.M. Kirby Foundation, gift in memory of Dr. Lee F. Mauger
Investigative Ophthalmology & Visual Science March 2012, Vol.53, 6428. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Joshua L. Dunaief, Majda Hadziahmetovic, Delu Song, Ying Song, Yafeng Li, Steve Grieco, Sally Chu, John Connelly, Michael Spino; Iron Chelation Protects Against Murine Retinal Degeneration Induced Through Diverse Mechanisms. Invest. Ophthalmol. Vis. Sci. 2012;53(14):6428.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : Iron is a potent generator of oxidative stress. We have shown previously that the oral iron chelator deferiprone (DFP) can protect against iron overload-induced retinal degeneration in Cp/Heph mice. Herein, we test whether DFP can be retina-protective in three mouse models where iron overload is not the primary cause of retinal degeneration.

Methods: : For light-induced oxidative damage A/J mice were gavaged with 75mg/kg DFP bid, or with saline (n = 4 each) and exposed to 10,000 lux cool white fluorescent light for 20 hours. Mice were sacrificed at different time points after light exposure. For NaIO3-induced retinal degeneration, C57BL/6 mice were gavaged with 75mg/kg DFP bid or saline for 7 days before and after tail vein injection of 25mg/kg NaIO3. Four-week old rd6 mice were exposed to drinking water with or without 1 mg/ml DFP (n = 4 each, approximate daily dose of 150mg/kg) for 6 months prior to sacrifice. Neurosensory retinas (NSR) and RPE were collected, and RNA was isolated. Gene expression was assessed using RT-PCR. Photoreceptor apoptosis was assessed using the TUNEL assay. Immunofluorescence was performed with antibodies detecting microglia/macrophage marker Iba1 and tight junction protein ZO-1. Retinal degeneration was assessed by histology.

Results: : Upregulation of retinal mRNA levels of oxidative stress-related genes and C3 by light exposure was partially prevented by DFP treatment. Robust microglial migration to the outer retina that occurred after light exposure was reduced by DFP treatment, as was the number of TUNEL-positive photoreceptors. In NaIO3-treated mice, DFP treatment protected against photoreceptor loss, decreased expression of oxidative stress-related genes and C3, and significantly increased markers of photoreceptor and RPE health, rhodopsin and RPE65. Retinal histology of rd6 mice (a model of hereditary retinal degeneration) treated with DFP showed partial protection against loss of photoreceptors.

Conclusions: : This study provides evidence that DFP provides retinal protection in light, chemical oxidant (NaIO3), and mutation (rd6)-induced retinal degeneration in which iron dysregulation is not the primary culprit, perhaps by diminishing oxidative stress. These data suggest that iron chelation should be explored as a potential treatment for retinal degeneration induced by a variety of insults.

Keywords: antioxidants • cell survival • retinal degenerations: cell biology 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×